Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome
Y Chen, XU Feng, Y Zhang, Q Ji, SUN Yi… - Chinese medical …, 2006 - journals.lww.com
Background Aspirin can inhibit inflammatory reactions and platelet aggregation, but little is
known about the effects of the combination of aspirin plus clopidogrel, a new antiplatelet
agent, on inflammation. The purpose of this study was to determine whether aspirin plus
clopidogrel can further suppress inflammation in patients with non-ST-segment elevation
acute coronary syndrome (NSTEACS). Methods One hundred and fifteen patients with
NSTEACS were randomized into two groups: group A (aspirin alone, n= 58) and group B …
known about the effects of the combination of aspirin plus clopidogrel, a new antiplatelet
agent, on inflammation. The purpose of this study was to determine whether aspirin plus
clopidogrel can further suppress inflammation in patients with non-ST-segment elevation
acute coronary syndrome (NSTEACS). Methods One hundred and fifteen patients with
NSTEACS were randomized into two groups: group A (aspirin alone, n= 58) and group B …
